Loading clinical trials...
Loading clinical trials...
Dose-Intensive Chemotherapy Combined With Monoclonal Antibody Therapy and Targeted Radioimmunotherapy for Untreated Patients With High-Risk B-Cell Non-Hodgkin's Lymphoma
Conditions
Interventions
cyclophosphamide
etoposide
+4 more
Locations
1
United States
Duke University Medical Center
Durham, North Carolina, United States
Start Date
June 18, 2005
Primary Completion Date
April 8, 2012
Completion Date
November 3, 2016
Last Updated
May 30, 2017
NCT04161248
NCT06528301
NCT05940272
NCT06534437
NCT05463263
NCT06609304
Lead Sponsor
Duke University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions